Critique of Medterra Featured on Medical News Today
In the ever-evolving world of health and wellness, CBD (Cannabidiol) has emerged as a popular alternative treatment for various health conditions. One company at the forefront of this movement is Medterra, a Kentucky-based firm that produces CBD products from hemp.
Medterra's range includes supplements, oils, gummies, and topicals, catering to a diverse array of consumer needs. The company prides itself on using high-quality hemp, extracted using liquid-state carbon dioxide, a gentler and more expensive method compared to other extraction techniques.
One of Medterra's unique offerings is the CBD Immune Boost Drops, which contain a blend of elderberry, echinacea, vitamin D, ginger, ashwagandha, vitamin C, reishi mushrooms, and lemon balm, aiming to support immune function. For pet lovers, Medterra Pets CBD Drops are available in beef flavor.
Medterra's Pain Relief Cream is designed to provide cooling relief from arthritis and joint pain, with menthol and arnica as key ingredients. For those struggling with sleep, Medterra offers Sleep Tight CBD Gummies, containing 99% CBD isolate and melatonin, and free from high fructose corn syrup and gelatin.
However, it's crucial to note that while CBD offers potential therapeutic benefits, such as treating seizures, reducing anxiety symptoms, and helping with chronic pain, multiple sclerosis, and chemotherapy-induced nausea and vomiting, further research is needed to fully understand its potential.
The FDA has approved one cannabis-derived drug, Epidiolex, to treat specific epilepsy syndromes. Yet, the FDA does not regulate CBD products in the same way as prescription medications, and products exceeding the 0.3% THC threshold are generally regulated as cannabis and are federally illegal, except where state medical or recreational cannabis laws provide exceptions.
Currently, under federal law in the United States, CBD products containing more than 0.3% THC are not legal as hemp-derived products. At the state level, laws vary significantly, with some states allowing CBD products only if they contain no more than 0.3% THC, while others permit CBD/THC products with THC greater than 0.3%, but strictly within qualifying medical frameworks and patient certifications.
Consumers and businesses should verify local laws and licensing requirements carefully, as this remains an evolving legal landscape with ongoing legislation and regulatory developments. Medterra, for its part, sends all its products to third-party labs for testing and posts the resulting Certificates of Analysis on its website, ensuring transparency and quality.
In conclusion, while CBD products offer promising therapeutic benefits, it's essential to understand the legal landscape and always consult with a healthcare provider before starting any new treatment regimen. With responsible use and continued research, CBD could play a significant role in health and wellness in the future.
[1] Farm Bill of 2018 [2] Federal Food, Drug, and Cosmetic Act [3] Controlled Substances Act [4] Drug Enforcement Administration [5] U.S. Department of Agriculture
- Medterra's CBD products, ranging from supplements to topicals, are produced from high-quality hemp using a gentle carbon dioxide extraction method.
- The CBD Immune Boost Drops by Medterra contain a blend of ingredients like elderberry, echinacea, and ashwagandha, aiming to support immune function.
- For pet owners, Medterra Pets CBD Drops are available in a beef flavor.
- Medterra's Pain Relief Cream is formulated with menthol and arnica to provide cooling relief from arthritis and joint pain.
- Sleep Tight CBD Gummies by Medterra, packed with 99% CBD isolate and melatonin, aim to help with sleep issues.
- While CBD offers potential benefits for a variety of medical conditions, including chronic pain, anxiety, and chronic kidney disease, COPD, type-2 diabetes, and rheumatoid arthritis, further research is necessary to fully understand its potential, as the FDA does not regulate CBD products in the same way as prescription medications.
